Mesoblast Ltd

Healthcare AU MSB

2.77AUD
0.02(0.73%)

Last update at 2025-01-23T05:10:00Z

Day Range

2.722.83
LowHigh

52 Week Range

0.263.37
LowHigh

Fundamentals

  • Previous Close 2.75
  • Market Cap3114.55M
  • Volume5829852
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-56.07700M
  • Revenue TTM5.90M
  • Revenue Per Share TTM0.006
  • Gross Profit TTM -35.16800M
  • Diluted EPS TTM-0.27

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -82.10100M -91.58600M -99.63000M -87.35500M -98.75400M
Minority interest - - - - -
Net income -81.88900M -91.34700M -98.81100M -77.94000M -89.79900M
Selling general administrative 25.37M 27.21M 30.87M 25.61M 21.62M
Selling and marketing expenses 27.73M 30.76M 32.72M 25.31M 15.36M
Gross profit -47.42100M -53.36100M -78.27500M -49.34100M 16.72M
Reconciled depreciation 4.11M 4.38M 4.26M 3.67M 2.14M
Ebit -69.13600M -80.95300M -111.86700M -79.07200M -83.30100M
Ebitda -65.02900M -76.57300M -107.60300M -75.40500M -81.16200M
Depreciation and amortization 4.11M 4.38M 4.26M 3.67M 2.14M
Non operating income net other - - - - -
Operating income -69.28900M -80.57400M -109.09600M -74.87200M -83.30100M
Other operating expenses 76.79M 90.78M 115.06M 107.56M 97.88M
Interest expense 19.44M 16.91M 10.71M 13.33M 11.33M
Tax provision -0.21200M -0.23900M -0.81900M -9.41500M -8.95500M
Interest income 18.78M 0.00300M 14.47M 14.47M 11.91M
Net interest income -19.29100M -17.28500M -10.71400M -13.33000M -10.98500M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.21200M -0.23900M -0.81900M -9.41500M -8.95500M
Total revenue 7.50M 10.21M 7.46M 32.16M 16.72M
Total operating expenses 76.79M 90.78M 115.06M 107.56M 97.88M
Cost of revenue 54.92M 63.57M 85.73M 81.50M 15.36M
Total other income expense net 6.48M 6.27M 18.69M 1.38M -15.45300M
Discontinued operations - - - - -
Net income from continuing ops -81.88900M -91.34700M -98.81100M -77.94000M -89.79900M
Net income applicable to common shares -81.88900M -91.34700M -98.81100M -77.94000M -89.79900M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 669.15M 669.41M 662.14M 744.72M 733.60M
Intangible assets 441.28M 442.73M 444.20M 446.09M 447.15M
Earning assets - - - - -
Other current assets - 0.40M 5.40M 6.76M 5.90M
Total liab 188.80M 167.58M 165.10M 163.32M 184.28M
Total stockholder equity 480.36M 501.84M 497.04M 581.40M 549.33M
Deferred long term liab - - - - -
Other current liab 4.65M 5.43M 2.19M 74.67M 65.17M
Common stock 1310.81M 1249.12M 1165.31M 1163.15M 1051.45M
Capital stock 1310.81M 1249.12M 1165.31M 1163.15M 1051.45M
Retained earnings -908.76100M -820.80500M -738.91600M -647.56900M -548.75800M
Other liab - 19.11M 15.02M 19.52M 30.79M
Good will 134.45M 134.45M 134.45M 134.45M 134.45M
Other assets - 2.33M 1.93M 1.72M 3.31M
Cash 62.56M 70.92M 60.03M 136.88M 129.33M
Cash and equivalents - -0.00200M 0.01M -0.04900M 0.01M
Total current liabilities 73.24M 41.98M 51.37M 94.27M 90.14M
Current deferred revenue 45.04M 6.40M 17.91M -55.96500M -35.97400M
Net debt 56.36M 45.58M 46.87M -31.38600M -30.01400M
Short term debt 16.49M 10.01M 8.20M 55.97M 35.97M
Short long term debt 13.86M 5.95M 5.02M 53.20M 32.45M
Short long term